Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

2.0K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.0K
Hemoglobin01:24

Hemoglobin

7.2K
Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
7.2K
Disorders of Hemostasis01:24

Disorders of Hemostasis

1.9K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.9K
Multiple Allele Traits01:49

Multiple Allele Traits

37.8K
The Concept of Multiple Allelism
37.8K
Oxygen Transport in the Blood01:27

Oxygen Transport in the Blood

5.7K
Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
5.7K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

3.0K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

COVID-19-Associated Portal Vein Thrombosis Post-Cholecystitis.

The International journal of angiology : official publication of the International College of Angiology, Inc·2023
Same author

Hematologic Conditions: Leukopenia.

FP essentials·2019
Same author

Hematologic Conditions: Leukocytosis and Leukemia.

FP essentials·2019
Same author

Hematologic Conditions: Platelet Disorders.

FP essentials·2019
Same author

Diabetes in the elderly: Matching meds to needs.

The Journal of family practice·2018
Same author

Transient Ion-Pair Separations for Electrospray Mass Spectrometry.

Analytical chemistry·2016
Same journal

Skin Cancer: Management of Cutaneous Melanoma.

FP essentials·2026
Same journal

Skin Cancer: Management of Actinic Keratoses and Keratinocyte Carcinomas.

FP essentials·2026
Same journal

Skin Cancer: Diagnosis.

FP essentials·2026
Same journal

Skin Cancer: Screening and Prevention.

FP essentials·2026
Same journal

Skin Cancer.

FP essentials·2026
Same journal

Obesity Management: Surgical Interventions.

FP essentials·2026
See all related articles

Related Experiment Video

Updated: Jan 5, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.9K

Hematologic Conditions: Common Hemoglobinopathies.

Barbara Keber1, Lily Lam1, James Mumford2

  • 1Department of Family Medicine at Zucker School of Medicine at Hofstra/Northwell, 500 Hofstra Blvd, Hempstead, NY 11549.

FP Essentials
|October 16, 2019
PubMed
Summary
This summary is machine-generated.

Hemoglobinopathies, like sickle cell disease and beta thalassemia, are genetic disorders affecting hemoglobin. Current treatments include blood transfusions, with stem cell transplantation as a potential cure.

More Related Videos

Measurement of Heme Synthesis Levels in Mammalian Cells
09:43

Measurement of Heme Synthesis Levels in Mammalian Cells

Published on: July 9, 2015

12.5K
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.7K

Related Experiment Videos

Last Updated: Jan 5, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.9K
Measurement of Heme Synthesis Levels in Mammalian Cells
09:43

Measurement of Heme Synthesis Levels in Mammalian Cells

Published on: July 9, 2015

12.5K
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.7K

Area of Science:

  • Genetics
  • Hematology
  • Molecular Biology

Background:

  • Hemoglobinopathies are inherited blood disorders characterized by abnormal hemoglobin structure.
  • These genetic mutations can alter hemoglobin's shape, oxygen transport, and propensity to aggregate, leading to vascular obstruction.
  • Sickle cell disease and beta thalassemia major are prevalent global hemoglobinopathies, though less common in the U.S. affecting approximately 101,000 individuals.

Purpose of the Study:

  • To provide an overview of hemoglobinopathies, focusing on sickle cell disease and beta thalassemia major.
  • To describe the genetic basis, clinical manifestations, and current therapeutic strategies for these conditions.

Main Methods:

  • Review of existing literature on hemoglobinopathies.
  • Analysis of disease presentation, complications, and treatment modalities.

Main Results:

  • Sickle cell disease involves abnormalities in hemoglobin S, with complications including pain crises and vasoocclusive events.
  • Beta thalassemia major, the most severe form, requires regular blood transfusions.
  • Blood transfusions are a primary therapy for both conditions, while stem cell transplantation offers a potential cure for beta thalassemia major.

Conclusions:

  • Hemoglobinopathies represent a significant group of genetic blood disorders with diverse clinical impacts.
  • Effective management relies on supportive care like transfusions, with ongoing research into curative therapies such as stem cell transplantation.